Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.
2.

Lupus erythematosus-like eruption due to D-penicillamine in progressive systemic sclerosis.

Tsankov NK, Lazarova AZ, Vasileva SG, Obreshkova EV.

Int J Dermatol. 1990 Oct;29(8):571-4.

PMID:
2147020
3.

[Yohimbine in therapy of erectile dysfunction].

Pittler MH.

Fortschr Med. 1998 Jan 20;116(1-2):32-3. Review. German.

PMID:
9522535
4.

Exacerbation of systemic lupus erythematosus induced by terbinafine.

Holmes S, Kemmett D.

Br J Dermatol. 1998 Dec;139(6):1133. No abstract available.

PMID:
9990401
5.

Drug-induced lupus erythematosus.

Sarzi-Puttini P, Atzeni F, Capsoni F, Lubrano E, Doria A.

Autoimmunity. 2005 Nov;38(7):507-18. Review. Retraction in: Autoimmunity. 2008 Apr;41(3):241.

PMID:
16373256
6.

Rifampicin-induced lupus erythematosus.

Patel GK, Anstey AV.

Clin Exp Dermatol. 2001 May;26(3):260-2.

PMID:
11422169
7.

Drug-induced lupus erythematosus.

Vedove CD, Del Giglio M, Schena D, Girolomoni G.

Arch Dermatol Res. 2009 Jan;301(1):99-105. doi: 10.1007/s00403-008-0895-5. Epub 2008 Sep 17. Review.

PMID:
18797892
8.

Acute severe adverse clozapine reaction resembling systemic lupus erythematosus.

Wickert WA, Campbell NR, Martin L.

Postgrad Med J. 1994 Dec;70(830):940-1. No abstract available.

9.

Severe Raynaud's phenomenon with yohimbine therapy for erectile dysfunction.

Johnson S, Iazzetta J, Dewar C.

J Rheumatol. 2003 Nov;30(11):2503-5.

PMID:
14677199
10.

Yohimbine treatment of organic erectile dysfunction in a dose-escalation trial.

Guay AT, Spark RF, Jacobson J, Murray FT, Geisser ME.

Int J Impot Res. 2002 Feb;14(1):25-31.

11.

Drug-induced lupus erythematosus.

Antonov D, Kazandjieva J, Etugov D, Gospodinov D, Tsankov N.

Clin Dermatol. 2004 Mar-Apr;22(2):157-66. Review.

PMID:
15234017
12.

Cutaneous manifestations of hydrallazine toxicity.

Petty R, Medley DR.

Br Med J. 1980 Feb 16;280(6212):482. No abstract available.

13.

Drug rash with eosinophilia and systemic symptoms after chlorambucil treatment in chronic lymphocytic leukaemia.

Vaida I, Roszkiewicz F, Gruson B, Makdassi R, Damaj G.

Pharmacology. 2009;83(3):148-9. doi: 10.1159/000187429. Epub 2008 Dec 20.

PMID:
19122478
14.

[Individualising the evidence--single case randomized trial].

Haefeli WE.

Ther Umsch. 2006 Dec;63(12):777-81. German.

PMID:
17133300
15.

Comparative safety of tetracycline, minocycline, and doxycycline.

Shapiro LE, Knowles SR, Shear NH.

Arch Dermatol. 1997 Oct;133(10):1224-30. Review.

PMID:
9382560
16.

[Iatrogenic lupus-like syndromes].

Demay-Wechsler P.

Rev Stomatol Chir Maxillofac. 1976 Jul-Aug;77(5):727-34. French.

PMID:
137511
17.

[Case of systemic lupus erythematosus occurring after induced abortion and drug eruption].

Sasaki N, Baba S, Takahashi S, Itou H, Kowada K, Shikanai T, Nakamura Y, Yamauchi K, Inoue H, Sawai T.

Arerugi. 2008 Jul;57(7):872-7. Japanese.

PMID:
18688188
18.

[Terbinafine-induced Stevens-Johnson syndrome and aggravation of systemic lupus erythematosus].

Terrab Z, El Ouazzani T, Zouhair K, El Kabli H, Lakhdar H.

Ann Dermatol Venereol. 2006 May;133(5 Pt 1):463-6. French.

PMID:
16760836
19.

Cutaneous side-effects of beta-adrenergic blockers.

Richards S.

Australas J Dermatol. 1985 Apr;26(1):25-8. No abstract available.

PMID:
2865950
20.

Cutaneous manifestations of systemic lupus erythematosus.

Yell JA, Mbuagbaw J, Burge SM.

Br J Dermatol. 1996 Sep;135(3):355-62.

PMID:
8949425

Supplemental Content

Support Center